Since SphK1/S1P1 represents a point where multiple signal pathways converge to regulate invasion, and SphK1 is expressed in all stages of HNSCC, targeting SphK1/S1P1 may be a successful route in the development of HNSCC therapy strategies. Here, SPHK1 is linked to head and neck squamous cell carcinoma.